Enzo Biochem Inc. ($0.01 Par Value)

1.36+0.0100+0.74%Vol 38.93K1Y Perf -41.81%
Oct 4th, 2023 16:00 DELAYED
BID1.35 ASK1.44
Open1.34 Previous Close1.35
Pre-Market- After-Market1.36
 - -  - -%
Target Price
12.00 
Analyst Rating
— 0.00
Potential %
782.35 
Finscreener Ranking
★★★★★     58.28
Insiders Trans % 3/6/12 mo.
100/100/100 
Value Ranking
★★     46.03
Insiders Value % 3/6/12 mo.
100/100/100 
Growth Ranking
★★     44.77
Insiders Shares Cnt. % 3/6/12 mo.
100/100/100 
Income Ranking
 —    -
Price Range Ratio 52W %
20.69 
Earnings Rating
Buy
Market Cap67.54M 
Earnings Date
13th Oct 2023
Alpha-0.01 Standard Deviation0.20
Beta0.96 

Today's Price Range

1.341.39

52W Range

1.002.74

5 Year PE Ratio Range

-100.90121.30

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-2.16%
1 Month
-12.82%
3 Months
-25.68%
6 Months
-44.03%
1 Year
-41.81%
3 Years
-38.46%
5 Years
-64.95%
10 Years
-46.03%

TickerPriceChg.Chg.%
ENZ1.360.01000.74
AAPL173.661.26000.73
GOOG136.272.97002.23
MSFT318.965.56501.78
XOM111.50-4.3300-3.74
WFC38.970.30000.78
JNJ155.520.18000.12
FB196.640.99000.51
GE108.851.09001.01
JPM143.350.64000.45
Financial StrengthValueIndustryS&P 500US Markets
1.00
1.80
0.26
0.43
-
Leverage Ratio 1.70
ProfitabilityValueIndustryS&P 500US Markets
34.70
-24.10
-21.10
-8.20
-27.31
RevenueValueIndustryS&P 500US Markets
98.83M
2.03
11.31
0.45
Earnings HistoryEstimateReportedSurprise %
Q03 2023--0.31-
Q02 2023--0.23-
Q01 2023--0.18-
Q03 2022--0.09-
Q02 2022-0.03-
Q01 2022--0.04-
Q03 2021-0.04-
Q02 2021-0.09-
Earnings Per EndEstimateRevision %Trend
1/2018 QR-0.010.00-
4/2018 QR0.00--
7/2018 FY-0.02--
7/2018 FY-0.030.00-
Next Report Date13th Oct 2023
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume38.93K
Shares Outstanding49.66K
Shares Float35.56M
Trades Count229
Dollar Volume52.85K
Avg. Volume202.85K
Avg. Weekly Volume110.01K
Avg. Monthly Volume166.85K
Avg. Quarterly Volume331.69K

Enzo Biochem Inc. ($0.01 Par Value) (NYSE: ENZ) stock closed at 1.36 per share at the end of the most recent trading day (a 0.74% change compared to the prior day closing price) with a volume of 38.93K shares and market capitalization of 67.54M. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 448 people. Enzo Biochem Inc. ($0.01 Par Value) CEO is Elazar Rabbani.

The one-year performance of Enzo Biochem Inc. ($0.01 Par Value) stock is -41.81%, while year-to-date (YTD) performance is -4.9%. ENZ stock has a five-year performance of -64.95%. Its 52-week range is between 1 and 2.74, which gives ENZ stock a 52-week price range ratio of 20.69%

Enzo Biochem Inc. ($0.01 Par Value) currently has a PE ratio of -2.50, a price-to-book (PB) ratio of 1.52, a price-to-sale (PS) ratio of 0.71, a price to cashflow ratio of 397.10, a PEG ratio of -, a ROA of -29.91%, a ROC of -34.75% and a ROE of -52.06%. The company’s profit margin is -27.31%, its EBITDA margin is -21.10%, and its revenue ttm is $98.83 Million , which makes it $2.03 revenue per share.

Of the last four earnings reports from Enzo Biochem Inc. ($0.01 Par Value), there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Enzo Biochem Inc. ($0.01 Par Value)’s next earnings report date is 13th Oct 2023.

The consensus rating of Wall Street analysts for Enzo Biochem Inc. ($0.01 Par Value) is (0), with a target price of $12, which is +782.35% compared to the current price. The earnings rating for Enzo Biochem Inc. ($0.01 Par Value) stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Enzo Biochem Inc. ($0.01 Par Value) has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Enzo Biochem Inc. ($0.01 Par Value) has a Sell technical analysis rating based on Technical Indicators (ADX : 13.41, ATR14 : 0.06, CCI20 : -65.88, Chaikin Money Flow : -0.44, MACD : -0.04, Money Flow Index : 54.61, ROC : 3.85, RSI : 38.53, STOCH (14,3) : 25.00, STOCH RSI : 0.00, UO : 31.39, Williams %R : -75.00), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Enzo Biochem Inc. ($0.01 Par Value) in the last 12-months were: Hamid Erfanian (Buy at a value of $197 000), James G. Wolf (Buy at a value of $144 740)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Summary Rating-
0.00
-
0.00
Strong Buy
1.00

Enzo Biochem Inc. ($0.01 Par Value)

Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment.

CEO: Elazar Rabbani

Telephone: +1 212 583-0100

Address: 527 Madison Avenue, New York 10022, NY, US

Number of employees: 448

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

53%47%

Bearish Bullish

52%48%

Bearish Bullish

54%46%

 

News

Stocktwits